Growth Metrics

West Pharmaceutical Services (WST) EBT Margin (2016 - 2025)

Historic EBT Margin for West Pharmaceutical Services (WST) over the last 17 years, with Q3 2025 value amounting to 21.36%.

  • West Pharmaceutical Services' EBT Margin fell 6600.0% to 21.36% in Q3 2025 from the same period last year, while for Sep 2025 it was 20.02%, marking a year-over-year decrease of 4500.0%. This contributed to the annual value of 20.24% for FY2024, which is 34300.0% down from last year.
  • According to the latest figures from Q3 2025, West Pharmaceutical Services' EBT Margin is 21.36%, which was down 6600.0% from 20.48% recorded in Q2 2025.
  • Over the past 5 years, West Pharmaceutical Services' EBT Margin peaked at 29.46% during Q2 2022, and registered a low of 15.83% during Q1 2025.
  • In the last 5 years, West Pharmaceutical Services' EBT Margin had a median value of 22.03% in 2023 and averaged 22.75%.
  • Per our database at Business Quant, West Pharmaceutical Services' EBT Margin surged by 98100bps in 2021 and then plummeted by -67300bps in 2022.
  • Over the past 5 years, West Pharmaceutical Services' EBT Margin (Quarter) stood at 24.89% in 2021, then dropped by -27bps to 18.16% in 2022, then grew by 27bps to 22.98% in 2023, then decreased by -4bps to 22.02% in 2024, then decreased by -3bps to 21.36% in 2025.
  • Its EBT Margin was 21.36% in Q3 2025, compared to 20.48% in Q2 2025 and 15.83% in Q1 2025.